Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-12

Clinical Trial Update: Pertussis Challenge Study in Adults Vaccinated With BPZE1 [Phase 2]

View source ↗

Summary

Phase 2 pertussis challenge study evaluating BPZE1 in adults has completed, with results posted. The trial assessed the vaccine's effect on pertussis protection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BPZE1 (Bordetella pertussis live attenuated vaccine BPZE1)

Snippet

Sponsor: ILiAD Biotechnologies | Conditions: Pertussis/Whooping Cough, Bordetella Pertussis, Whooping Cough | Phase 2 | Status: COMPLETED | Results posted: 2025-03-12